KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to -$1.0 billion.

  • Exact Sciences' Net Income towards Common Stockholders rose 48.76% to -$19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$986.6 million, marking a year-over-year decrease of 360.86%. This contributed to the annual value of -$1.0 billion for FY2024, which is 403.97% down from last year.
  • As of FY2024, Exact Sciences' Net Income towards Common Stockholders stood at -$1.0 billion, which was down 403.97% from -$204.1 million recorded in FY2023.
  • In the past 5 years, Exact Sciences' Net Income towards Common Stockholders registered a high of -$204.1 million during FY2023, and its lowest value of -$1.0 billion during FY2024.
  • For the 3-year period, Exact Sciences' Net Income towards Common Stockholders averaged around -$618.8 million, with its median value being -$623.5 million (2022).
  • In the last 5 years, Exact Sciences' Net Income towards Common Stockholders soared by 67.26% in 2023 and then crashed by 403.97% in 2024.
  • Yearly analysis of 5 years shows Exact Sciences' Net Income towards Common Stockholders stood at -$823.6 million in 2020, then grew by 27.68% to -$595.6 million in 2021, then decreased by 4.68% to -$623.5 million in 2022, then spiked by 67.26% to -$204.1 million in 2023, then slumped by 403.97% to -$1.0 billion in 2024.